The inhibition of humanimmunodeficiency virus (HIV) reverse transcriptase by certain antibiotics and related compounds was studied in comparisonwith that of avian myeloblastosis virus (AMV)reverse transcriptase and cellular DNApolymerases a and £. In general, compoundsthat inhibited HIVreverse transcriptase also inhibited AMV reverse transcriptase. For example, 10^g/ml of the isoquinoline quinones used in this study inhibited approximately 80 % of the activity of reverse transcriptases of HIV and AMV,but did not inhibit the activity of DNApolymerases a and fi even at 50^g/ml. AMV enzymewas more sensitive than HIV enzyme to colistin, enduracidins A and B, janiemycin, glysperin A, and thielavins A and B. The streptonigrin alkyl esters, however, inhibited HIVreverse transcriptase only. Sakyomicin A, luzopeptins, ellagic acid and suramine inhibited the activities of reverse transcriptases and cellular DNApolymerases.
The inhibition of humanimmunodeficiency virus (HIV) reverse transcriptase by certain antibiotics and related compounds was studied in comparisonwith that of avian myeloblastosis virus (AMV)reverse transcriptase and cellular DNApolymerases a and £. In general, compoundsthat inhibited HIVreverse transcriptase also inhibited AMV reverse transcriptase. For example, 10^g/ml of the isoquinoline quinones used in this study inhibited approximately 80 % of the activity of reverse transcriptases of HIV and AMV,but did not inhibit the activity of DNApolymerases a and fi even at 50^g/ml. AMV enzymewas more sensitive than HIV enzyme to colistin, enduracidins A and B, janiemycin, glysperin A, and thielavins A and B. The streptonigrin alkyl esters, however, inhibited HIVreverse transcriptase only. Sakyomicin A, luzopeptins, ellagic acid and suramine inhibited the activities of reverse transcriptases and cellular DNApolymerases.
Reverse transcription, a step catalyzed by the unique DNApolymerase, reverse transcriptase, is a pivotal step in the replication of retroviruses and in the stable inheritance of viral genome. An effective inhibitor of reverse transcriptase may selectively block viral replication and therefore, the enzyme has been one of the molecular targets in antiviral studies for manyyears. We have undertaken a search for inhibitors of avian myeloblastosis virus (AMV)reverse transcriptase among antibiotics and related compounds. Humanimmunodeficiency virus (HIV), a causative agent for acquired im- 
Materials and Methods

Materials
AMV reverse transcriptase was purchased from Seikagaku KogyoCo., Ltd. HIV reverse trans-criptase was isolated using the recombinant DNAmethod13. The coding sequence for the "pol" region of HIVI was inserted into a derivative of the bacterial PAS1expression vector. The enzyme expressed in Escherichia coli was purified using affinity chromatography13. DNApolymerases a and /3 were isolated from leukocytes of a patient with acute myelogeneous leukemia. They were purified by successive chromatography using DEAE-cellulose, phosphocellulose and single-stranded DNA-cellulose columns according to the procedures described previously2*33. The purified enzymes were free of cross contamination and resemble respective viral and cellular DNA polymerases in that they displayed normal preferences of template/primer and monovalent and divalent cations, and sensitivities to certain inhibitors. Poly(dA) and poly(rA) were purchased from Sigma Chemical Company. Oligo(dT)12_18 was obtained from Pharmacia Fine Chemicals Co. [Methyl-3H]TTPwas a product of NewEngland Nuclear. All other chemicals were commercial products of the analytical grade.
Assay Methods
The detailed assay methods for DNApolymerases a and ft were described by Allaudeen et alP and Allaudeen and Bertino3). AMV reverse transcriptase was assayed by the previous method4'53. Assay of HIV reverse transcriptase was carried out employing the reaction conditions reported by Hoffman et al.ey with some modifications73. Briefly, a reaction mixture (100^1) consisting of Tris-HC1 50mM (pH 7.8), dithiothreitol (DTT) 5 m, MgCl2 5 mM, KC1 150mM, Triton X-100 0.05%, glutathione 0.3 mM,ethylene glycol bis(2-aminoethyl ether) tetraacetic acid (EGTA) 0.5 mM,poly(rA) 50 jwg/ml, oligo(dT)12_18 12 jig/ml, [3H]TTP 10.0 im (4.8 Ci/mmol) and enzyme was incubated at 37°C for 60 minutes. Acid insoluble fractions were collected on a MF-Millipore filter paper (HA 0.45^m), washed several times with 5 %TCA containing 2 mMsodium pyrophosphate and once with 70 % ethanol and air dried. The radioactivity remaining on the filter paper was determined in a liquid scintillation counter.
Results
The results are shown in Tables 1 to 5 , in which the inhibition exceeding 70% at the high dose (50 or 40^g/ml) and/or 50% at the low dose (10 /*g/ml) was defined to be significant.
In a primary screening using AMVreverse transcriptase, those compounds listed in Table 1 selective inhibitors of AMV reverse transcriptase (Table 2) , 2) compounds which inhibit both AMV and HIVreverse transcriptases without affecting cellular DNA polymerases (Table 3) , and 3) non-specific inhibitors (Table 4) . Streptonigrin and luzopeptins A, B and C are amongthe most potent inhibitors of AMV reverse transcriptase.
Previously, we observed that the streptonigrin C-2' amide derivatives such as the glycine derivative (STN-7) inhibited AMV reverse transcriptase to the sameextent as streptonigrin40, whereas streptonigrin methyl ester (STN-1) did not inhibit the enzyme activity4>8). As well as STN-7, the other streptonigrin amide derivatives, STN-8, 9 and 10, inhibited the reverse transcriptases from AMVand HIV to an equal extent ( Table 3) . Four of the ester derivatives of streptonigrin, STN-1, 2, 3 and 4, inhibited only the reverse transcriptase of HIV but the other three enzymes were not inhibited by them (Table 5 ). This observation is consistent with the report by Chirigos et al. 8 ) who showed that STN-1 did not inhibit the AMVreverse transcritrtase activitv. It is worth notins that the parent compound,streptonigrin, inhibited the activity of AMVreverse transcriptase but not cellular DNApolymerases examined63. Although the ester derivatives, STN-1 to STN-4, lacked the ability to inhibit AMVreverse transcriptase, the dimethylamino group endowed the ester derivatives with inhibitory activity against not only AMVreverse transcriptase but also HIV enzyme (see the results for STN-5 and 6 in Table 3 ). Wehave included the quinoline quinones in our study because of their structural resemblance to streptonigrin9"123. As in the case of streptonigrin, they are potent inhibitors of both AMVand HIV reverse transcriptases, but not cellular DNApolymerases (Table 3) . For example, the quinones used in this study, at 10^g/ml, inhibited the reverse transcriptases of HIV and AMVapproximately 80%; they did not inhibit the DNApolymerases a and $ activities even at 50 iMg/ml. Sakyomicin A showed moderate inhibition of AMV reverse transcriptase133; the inhibition values at 40 and 10^g/ml were 63 and 26%, respectively. The role of naphthoquinone moiety as the minimumrequisite for this activity was confirmed previously143. Besides AMVreverse transcriptase, HIV enzyme was inhibited by sakyomicin A and the naphthoquinone derivatives such as NQ-1, 2, 3 (Table 2) , whereas luzopeptins A, B and C15) inhibited all the enzymes tested potently and non-specifically (Table 4 ). In spite of structural resemblance to luzopeptins, echinomycin and triostin A were not inhibitory against AMVreverse transcriptase (Table 1) .
Suramin as well as ellagic acid inhibited all the four enzymes (Table 4 ). Doxorubicin16), glysperin A, and thielavins A and B were inhibitory to only AMVreverse transcriptase (Table 2) . 27  21  32  27  6  25  13  8  15  0  23   0   17  13  1  0  0  4  0  0  2  10   70  89  67  70  74  80  89  80  95  85  100   30  49  50  28  60  29  56  56  30  80  94 Abbreviations : DP, DNA polymerase; HIV-RT, HIV reverse transcriptase ; AMV-RT, AMV reverse transcriptase. a Template/primer, b concentration (/jg/ml), c synthetic compounds, d compound of plant origin. 34  21  21  43  25  43  38  0  0  0  14  0  14  25  40  59  56  66  44   27  35  38  28  23  26  21  28  19  33  28  0  0  0  0  0  0  16  23  41  45  23 a Template/primer, b concentration (^g/ml). JAN. 1989 Discussion Manycompoundsused in this study inhibited the reverse transcriptases of HIVand AMV. However, some compounds listed in Table 2 inhibited preferentially AMVreverse transcriptase; the ester derivatives of streptonigrin, on the other hand, inhibited HIVreverse transcriptase only. Such differences between the reverse transcriptases of HIVand AMV and the structure activity relationship data obtained using these compoundsmay be exploited in designing better and more selective inhibitors.
As for quinone compoundssuch as streptonigrin and sakyomicin A, we have proposed the existence of a specific site of interaction, referred to as a "quinone pocket", on AMV reverse transcriptase1^. On the basis of the results shown in Table 3 , we postulate that HIV reverse transcriptase also possesses a "quinone pocket" which is concerned with the sensitivity of this enzymeto quinone compounds of both synthetic and natural origins.
Amongthe peptide group antibiotics, luzopeptins showed a significant inhibition of HIV reverse transcriptase; however they also inhibited the other enzymes used in this study. The effects of luzopeptin C, janiemycin and colistin on the in vitro replication of HIVhave been reported earlier15). The replication of HIVin MT-4cells was suppressed in the presence of luzopeptin C at the concentrations not affecting cell viability. Meantime, no effect on viral replication and cell viability was observed in the case of the other antibiotics. Which function of luzopeptin C plays a crucial role in the inhibition of in vitro HIVreplication, however, remains to be clarified.
